The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

Sara Sheikhbahaei, Esther Mena, Anusha Yanamadala, Siddaling Reddy, Lilja Solnes, Jason Wachsmann, Rathan M. Subramaniam

Research output: Contribution to journalReview article

Abstract

OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION. FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.

Original languageEnglish (US)
Pages (from-to)420-433
Number of pages14
JournalAmerican Journal of Roentgenology
Volume208
Issue number2
DOIs
StatePublished - Feb 1 2017

Keywords

  • FDG PET/CT
  • Follow-up
  • Lung cancer
  • Recurrence detection
  • Therapy assessment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer'. Together they form a unique fingerprint.

  • Cite this